195 related articles for article (PubMed ID: 30995468)
1. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
[TBL] [Abstract][Full Text] [Related]
2. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
3. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Kalender A; Selvaraj A; Kim SY; Gulati P; Brûlé S; Viollet B; Kemp BE; Bardeesy N; Dennis P; Schlager JJ; Marette A; Kozma SC; Thomas G
Cell Metab; 2010 May; 11(5):390-401. PubMed ID: 20444419
[TBL] [Abstract][Full Text] [Related]
4. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
[TBL] [Abstract][Full Text] [Related]
5. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.
Woollhead AM; Sivagnanasundaram J; Kalsi KK; Pucovsky V; Pellatt LJ; Scott JW; Mustard KJ; Hardie DG; Baines DL
Br J Pharmacol; 2007 Aug; 151(8):1204-15. PubMed ID: 17603555
[TBL] [Abstract][Full Text] [Related]
7. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
8. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
[TBL] [Abstract][Full Text] [Related]
9. IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells.
Antonia RJ; Baldwin AS
Sci Signal; 2018 Jul; 11(538):. PubMed ID: 29991651
[TBL] [Abstract][Full Text] [Related]
10. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
11. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
12. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
Shackelford DB; Abt E; Gerken L; Vasquez DS; Seki A; Leblanc M; Wei L; Fishbein MC; Czernin J; Mischel PS; Shaw RJ
Cancer Cell; 2013 Feb; 23(2):143-58. PubMed ID: 23352126
[TBL] [Abstract][Full Text] [Related]
13. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
Liu JL; Mao Z; Gallick GE; Yung WK
Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
[TBL] [Abstract][Full Text] [Related]
14. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration.
Zhang L; He H; Balschi JA
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H457-66. PubMed ID: 17369473
[TBL] [Abstract][Full Text] [Related]
15. The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.
Rosilio C; Lounnas N; Nebout M; Imbert V; Hagenbeek T; Spits H; Asnafi V; Pontier-Bres R; Reverso J; Michiels JF; Sahra IB; Bost F; Peyron JF
Cancer Lett; 2013 Aug; 336(1):114-26. PubMed ID: 23612073
[TBL] [Abstract][Full Text] [Related]
16. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
17. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation.
Tosello V; Bongiovanni D; Di Martino L; Franchin C; Zanovello P; Arrigoni G; Piovan E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203724
[TBL] [Abstract][Full Text] [Related]
19. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
[TBL] [Abstract][Full Text] [Related]
20. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
Grimaldi C; Chiarini F; Tabellini G; Ricci F; Tazzari PL; Battistelli M; Falcieri E; Bortul R; Melchionda F; Iacobucci I; Pagliaro P; Martinelli G; Pession A; Barata JT; McCubrey JA; Martelli AM
Leukemia; 2012 Jan; 26(1):91-100. PubMed ID: 21968881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]